Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction
Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. Methods In 38,689 consecutive patients with acute myocardial infarction from the Cerner Healt...
Saved in:
Published in | The American journal of medicine Vol. 129; no. 8; pp. 858 - 865 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.08.2016
Elsevier Sequoia S.A |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. Methods In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. Results Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Conclusions Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study. |
---|---|
AbstractList | BACKGROUNDHyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described.METHODSIn 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated.RESULTSOf 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality.CONCLUSIONSHyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study. Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. Methods In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. Results Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Conclusions Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study. Grodzinsky et al determine the contemporary prevalence and prognostic importance of hyperkalemia after acute myocardial infarction. Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial infarction are not well described. In 38,689 consecutive patients with acute myocardial infarction from the Cerner Health Facts database, we evaluated the association between maximum in-hospital potassium levels and in-hospital mortality. Patients were stratified by dialysis status and grouped by maximum potassium as follows: <5 mEq/L, 5 to <5.5 mEq/L, 5.5 to <6.0 mEq/L, 6.0 to <6.5 mEq/L, and ≥6.5 mEq/L. Multivariable logistic regression was used to adjust for multiple patient and site characteristics. The relationship between the number of hyperkalemic values and the in-hospital mortality was evaluated. Of 38,689 patients with acute myocardial infarction, 886 were on dialysis. The rate of hyperkalemia (maximum potassium ≥5.0 mEq/L) was 22.6% in patients on dialysis and 66.8% in patients not on dialysis. Moderate to severe hyperkalemia (maximum potassium ≥5.5 mEq/L) occurred in 9.8% of patients. There was a steep increase in mortality with higher maximum potassium levels. In-hospital mortality exceeded 15% once maximum potassium was ≥5.5 mEq/L regardless of dialysis status. The relationship between higher maximum potassium and increased mortality risk persisted after multivariable adjustment. In addition, patients with a greater number of hyperkalemic values (vs a single value) experienced higher in-hospital mortality. Hyperkalemia is common in patients who are hospitalized with acute myocardial infarction. Higher maximum potassium levels and number of hyperkalemic events are associated with a steep mortality increase, with higher risks for adverse outcomes observed even at mild levels of hyperkalemia. Whether more intensive management of hyperkalemia may improve outcomes in patients with acute myocardial infarction merits further study. |
Author | Fonarow, Gregg C., MD Gosch, Kensey, MS Grodzinsky, Anna, MD, MSc Mebazaa, Alexandre, MD Kosiborod, Mikhail, MD Masoudi, Frederick A., MD, MSPH Goyal, Abhinav, MD, MHS Palmer, Biff F., MD Spertus, John A., MD, MPH McCullough, Peter A., MD, MPH |
AuthorAffiliation | 6 Division of Nephrology, University of Texas Southwestern Medical Center 3 Division of Cardiology, Emory Healthcare, and Emory School of Medicine, Atlanta, GA 5 Division of Cardiology, University of California-Los Angeles, Los Angeles, CA 1 Saint Luke’s Mid America Heart Institute, Kansas City, MO 7 Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO 8 Department of Anesthesia and Critical Care Medicine, Hôpitaux Universitaire, Saint Louis Lariboisière; U-942 Inserm; University Paris Diderot, Sorbonne Paris Cité, Paris, France 2 University of Missouri-Kansas City, Kansas City, MO 4 Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, The Heart Hospital, Plano, TX |
AuthorAffiliation_xml | – name: 5 Division of Cardiology, University of California-Los Angeles, Los Angeles, CA – name: 3 Division of Cardiology, Emory Healthcare, and Emory School of Medicine, Atlanta, GA – name: 6 Division of Nephrology, University of Texas Southwestern Medical Center – name: 1 Saint Luke’s Mid America Heart Institute, Kansas City, MO – name: 4 Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, TX, The Heart Hospital, Plano, TX – name: 7 Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO – name: 2 University of Missouri-Kansas City, Kansas City, MO – name: 8 Department of Anesthesia and Critical Care Medicine, Hôpitaux Universitaire, Saint Louis Lariboisière; U-942 Inserm; University Paris Diderot, Sorbonne Paris Cité, Paris, France |
Author_xml | – sequence: 1 fullname: Grodzinsky, Anna, MD, MSc – sequence: 2 fullname: Goyal, Abhinav, MD, MHS – sequence: 3 fullname: Gosch, Kensey, MS – sequence: 4 fullname: McCullough, Peter A., MD, MPH – sequence: 5 fullname: Fonarow, Gregg C., MD – sequence: 6 fullname: Mebazaa, Alexandre, MD – sequence: 7 fullname: Masoudi, Frederick A., MD, MSPH – sequence: 8 fullname: Spertus, John A., MD, MPH – sequence: 9 fullname: Palmer, Biff F., MD – sequence: 10 fullname: Kosiborod, Mikhail, MD |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27060233$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAQtVAR3Rb-AUKWuHBJGH8k2VyQqqrQSkWsBD1bXnvSOk3sxc4u2n-Poy0t9MLBsqx58zzvvTkhRz54JOQtg5IBqz_2pR77EW3J86sEUQIsX5AFq6qqaFjNj8gCAHjRCimOyUlKfX5CW9WvyDFvoAYuxILcrCLu9IDeINXe0lUMtz4kl2jo6OV-g_E-V0enqfN0pSeHfkr0l5vu6JnZTki_7oPR0To90Cvf6WgmF_xr8rLTQ8I3D_cpufl88eP8srj-9uXq_Oy6MJWsp0JazdYSrW2ZWHfMInRdxxvJAY0xHEDarq216SQ069YIwbXW1tQgcSm0leKUfDrwbrbrbIXJw0U9qE10o457FbRT_1a8u1O3YacqECw7lQk-PBDE8HOLaVKjSwaHQXsM26TYEhrIh9UZ-v4ZtA_b6LO8jGLLBiRUIqPkAWViSCli9zgMAzXnpnp1yE3NuSkQKueW2979LeSx6U9QT0ox27lzGFUybk7NuohmUja4__3wnMAMzjujh3vcY3rSohJXoL7PuzOvTlaevWoq8Rs708Nn |
CODEN | AJMEAZ |
CitedBy_id | crossref_primary_10_1097_PCC_0000000000002391 crossref_primary_10_1097_PCC_0000000000002351 crossref_primary_10_1055_s_0040_1719172 crossref_primary_10_1016_j_mayocp_2020_06_014 crossref_primary_10_1186_s12937_023_00888_z crossref_primary_10_1080_14656566_2020_1810234 crossref_primary_10_1177_2047487318780466 crossref_primary_10_1080_14656566_2021_1891223 crossref_primary_10_1093_bja_aex163 crossref_primary_10_7759_cureus_10401 crossref_primary_10_1001_jamanetworkopen_2021_38420 crossref_primary_10_1093_ndt_gfy249 crossref_primary_10_1080_0886022X_2023_2212800 crossref_primary_10_1080_21548331_2021_1925554 crossref_primary_10_3389_fcvm_2023_1129235 crossref_primary_10_5863_1551_6776_27_4_358 crossref_primary_10_1016_j_bbrc_2018_04_026 crossref_primary_10_1177_2047487318759694 crossref_primary_10_1681_ASN_2016121344 crossref_primary_10_1016_j_medcli_2017_03_013 crossref_primary_10_1016_j_ijcard_2020_08_044 crossref_primary_10_1053_j_ajkd_2021_07_008 crossref_primary_10_1097_CCM_0000000000003521 crossref_primary_10_1161_JAHA_118_011814 crossref_primary_10_1016_j_medcle_2017_03_014 crossref_primary_10_15441_ceem_16_194 crossref_primary_10_1016_j_cjco_2023_10_011 crossref_primary_10_1016_j_ajem_2021_02_005 crossref_primary_10_1016_j_jemermed_2018_09_007 crossref_primary_10_15441_ceem_17_207 |
Cites_doi | 10.3909/ricm0727 10.1016/j.jacc.2014.05.040 10.1161/CIRCULATIONAHA.108.778811 10.1001/jama.2014.15688 10.1590/S0066-782X2008000300004 10.1056/NEJMoa1410853 10.1161/CIRCULATIONAHA.104.492348 10.1097/MAJ.0b013e318279b105 10.1186/cc11872 10.1016/S0002-9343(00)00496-4 10.1007/s00134-012-2636-7 10.1016/j.ccc.2004.12.003 10.1016/0002-9149(85)91110-5 10.1161/hc4101.096153 10.1056/NEJMoa1411487 10.1001/jama.2011.1967 10.1056/NEJMoa040135 10.2215/CJN.01970310 |
ContentType | Journal Article |
Copyright | Elsevier Inc. 2016 Elsevier Inc. Copyright © 2016 Elsevier Inc. All rights reserved. Copyright Elsevier Science Ltd. Aug 2016 |
Copyright_xml | – notice: Elsevier Inc. – notice: 2016 Elsevier Inc. – notice: Copyright © 2016 Elsevier Inc. All rights reserved. – notice: Copyright Elsevier Science Ltd. Aug 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK 7TO 7TS 7U9 H94 K9. 7X8 5PM |
DOI | 10.1016/j.amjmed.2016.03.008 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Neurosciences Abstracts Oncogenes and Growth Factors Abstracts Physical Education Index Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Virology and AIDS Abstracts Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Neurosciences Abstracts Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Virology and AIDS Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1555-7162 |
EndPage | 865 |
ExternalDocumentID | 4179725011 10_1016_j_amjmed_2016_03_008 27060233 S0002934316303175 1_s2_0_S0002934316303175 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: National Heart, Lung, and Blood Institute grantid: T32HL110837 funderid: http://dx.doi.org/10.13039/100000050 – fundername: NHLBI NIH HHS grantid: T32 HL110837 |
GroupedDBID | --- --K -~X .-4 .1- .55 .FO .GJ 0R~ 0SF 123 1B1 1CY 1P~ 1RT 1~5 23M 3O- 4.4 457 4CK 4G. 53G 5RE 5VS 6J9 7-5 AACTN AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAWTL AAXUO AAYOK ABLJU ABMAC ABOCM ABPPZ ACGFO ACIUM ACKOT ACPRK ADBBV ADMUD ADPAM ADVLN AENEX AEVXI AFCTW AFFNX AFHKK AFJKZ AFRHN AFTJW AGHFR AHHHB AHMBA AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BELOY BKOMP C5W CS3 EBS EFJIC EJD EX3 F5P FDB FEDTE FGOYB FIRID G-2 G-Q GBLVA HEA HMK HMO HVGLF HZ~ IH2 IHE J1W J5H K-O KOM L7B LZ2 M29 M41 MO0 MVM N4W N9A NCXOZ NQ- O9- OD. OHT OO~ P2P PC. PQQKQ R2- RIG ROL RPZ SAE SEL SES SSZ TWZ UBY UHB UHU UNMZH UV1 WH7 WOW WUQ X7M XH2 XPP YFH YOC YQJ YYQ Z5R ZGI ZUP ZXP AAIAV AGZHU AHPSJ ALXNB ZA5 CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 7TK 7TO 7TS 7U9 H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c546t-4da1b4edd913bf1de0fff27420eccc2004df96acf407b9c332aaadc604e83ad43 |
ISSN | 0002-9343 |
IngestDate | Tue Sep 17 21:12:28 EDT 2024 Fri Aug 16 07:22:54 EDT 2024 Thu Oct 10 15:57:58 EDT 2024 Thu Sep 26 17:42:36 EDT 2024 Sat Sep 28 08:46:11 EDT 2024 Fri Feb 23 02:17:03 EST 2024 Tue Oct 15 14:37:25 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Acute myocardial infarction Hyperkalemia prevalence Dialysis |
Language | English |
License | Copyright © 2016 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c546t-4da1b4edd913bf1de0fff27420eccc2004df96acf407b9c332aaadc604e83ad43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc5031155?pdf=render |
PMID | 27060233 |
PQID | 1818704053 |
PQPubID | 950 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5031155 proquest_miscellaneous_1807080716 proquest_journals_1818704053 crossref_primary_10_1016_j_amjmed_2016_03_008 pubmed_primary_27060233 elsevier_sciencedirect_doi_10_1016_j_amjmed_2016_03_008 elsevier_clinicalkeyesjournals_1_s2_0_S0002934316303175 |
PublicationCentury | 2000 |
PublicationDate | 2016-08-01 |
PublicationDateYYYYMMDD | 2016-08-01 |
PublicationDate_xml | – month: 08 year: 2016 text: 2016-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | The American journal of medicine |
PublicationTitleAlternate | Am J Med |
PublicationYear | 2016 |
Publisher | Elsevier Inc Elsevier Sequoia S.A |
Publisher_xml | – name: Elsevier Inc – name: Elsevier Sequoia S.A |
References | An, Lee, Jeon (bib2) 2012; 16 McMahon, Mendu, Gibbons, Christopher (bib14) 2012; 38 Fordjour, Walton, Doran (bib10) 2014; 347 Wozakowska-Kaplon, Janowska-Molenda (bib8) 2009; 119 Nordrehaug (bib15) 1985; 56 McCullough, Beaver, Bennett-Guerrero (bib3) 2014; 15 Pitt, Bakris, Ruilope, DiCarlo, Mukherjee (bib6) 2008; 118 Schoolwerth, Sica, Ballermann, Wilcox (bib16) 2001; 104 Juurlink, Mamdani, Lee (bib7) 2004; 351 Goyal, Spertus, Gosch (bib1) 2012; 307 Moore, Bailey (bib17) 1989; 102 Garovic, Textor (bib12) 2005; 112 Salisbury, Reid, Marso (bib13) 2014; 64 US Department of Health and Human Services. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Centers for Disease Control and Prevention. Available at Kosiborod, Rasmussen, Lavin (bib20) 2014; 312 Perazella (bib9) 2000; 109 Lima, Ochiai, Cardoso, Morgado, Munhoz, Barretto (bib18) 2008; 91 Accessed May 1, 2015. Weir, Bakris, Bushinsky (bib19) 2015; 372 Packham, Rasmussen, Lavin (bib21) 2015; 372 Weir, Juurlink, Gomes (bib5) 2010; 5 McCullough, Soman (bib11) 2005; 21 16129817 - Circulation. 2005 Aug 30;112(9):1362-74 15781162 - Crit Care Clin. 2005 Apr;21(2):261-80 23171442 - Crit Care. 2012 Nov 21;16(6):R225 22806439 - Intensive Care Med. 2012 Nov;38(11):1834-42 19514643 - Pol Arch Med Wewn. 2009 Mar;119(3):141-7 10996582 - Am J Med. 2000 Sep;109(4):307-14 4036815 - Am J Cardiol. 1985 Aug 30;56(6):20D-23D 20595693 - Clin J Am Soc Nephrol. 2010 Sep;5(9):1544-51 18824643 - Circulation. 2008 Oct 14;118(16):1643-50 15295047 - N Engl J Med. 2004 Aug 5;351(6):543-51 11602506 - Circulation. 2001 Oct 16;104(16):1985-91 25415807 - N Engl J Med. 2015 Jan 15;372(3):222-31 23255245 - Am J Med Sci. 2014 Feb;347(2):93-100 25145526 - J Am Coll Cardiol. 2014 Aug 26;64(8):811-9 18853060 - Arq Bras Cardiol. 2008 Sep;91(3):177-82, 194-9 24762462 - Rev Cardiovasc Med. 2014;15(1):11-23 25415805 - N Engl J Med. 2015 Jan 15;372(3):211-21 25402495 - JAMA. 2014 Dec 3;312(21):2223-33 2812582 - N Z Med J. 1989 Oct 25;102(878):557-8 22235086 - JAMA. 2012 Jan 11;307(2):157-64 Schoolwerth (10.1016/j.amjmed.2016.03.008_bib16) 2001; 104 Moore (10.1016/j.amjmed.2016.03.008_bib17) 1989; 102 McCullough (10.1016/j.amjmed.2016.03.008_bib3) 2014; 15 Juurlink (10.1016/j.amjmed.2016.03.008_bib7) 2004; 351 McCullough (10.1016/j.amjmed.2016.03.008_bib11) 2005; 21 Kosiborod (10.1016/j.amjmed.2016.03.008_bib20) 2014; 312 Packham (10.1016/j.amjmed.2016.03.008_bib21) 2015; 372 McMahon (10.1016/j.amjmed.2016.03.008_bib14) 2012; 38 Goyal (10.1016/j.amjmed.2016.03.008_bib1) 2012; 307 Pitt (10.1016/j.amjmed.2016.03.008_bib6) 2008; 118 Garovic (10.1016/j.amjmed.2016.03.008_bib12) 2005; 112 Weir (10.1016/j.amjmed.2016.03.008_bib5) 2010; 5 An (10.1016/j.amjmed.2016.03.008_bib2) 2012; 16 Wozakowska-Kaplon (10.1016/j.amjmed.2016.03.008_bib8) 2009; 119 Salisbury (10.1016/j.amjmed.2016.03.008_bib13) 2014; 64 Weir (10.1016/j.amjmed.2016.03.008_bib19) 2015; 372 Fordjour (10.1016/j.amjmed.2016.03.008_bib10) 2014; 347 Lima (10.1016/j.amjmed.2016.03.008_bib18) 2008; 91 Perazella (10.1016/j.amjmed.2016.03.008_bib9) 2000; 109 10.1016/j.amjmed.2016.03.008_bib4 Nordrehaug (10.1016/j.amjmed.2016.03.008_bib15) 1985; 56 |
References_xml | – volume: 21 start-page: 261 year: 2005 end-page: 280 ident: bib11 article-title: Contrast-induced nephropathy publication-title: Crit Care Clin contributor: fullname: Soman – volume: 91 start-page: 177 year: 2008 end-page: 182 ident: bib18 article-title: Hyperkalemia during spironolactone use in patients with decompensated heart failure publication-title: Arq Bras Cardiol contributor: fullname: Barretto – volume: 118 start-page: 1643 year: 2008 end-page: 1650 ident: bib6 article-title: Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) publication-title: Circulation contributor: fullname: Mukherjee – volume: 102 start-page: 557 year: 1989 end-page: 558 ident: bib17 article-title: Hyperkalaemia in patients in hospital publication-title: N Z Med J contributor: fullname: Bailey – volume: 307 start-page: 157 year: 2012 end-page: 164 ident: bib1 article-title: Serum potassium levels and mortality in acute myocardial infarction publication-title: JAMA contributor: fullname: Gosch – volume: 38 start-page: 1834 year: 2012 end-page: 1842 ident: bib14 article-title: Association between hyperkalemia at critical care initiation and mortality publication-title: Intensive Care Med contributor: fullname: Christopher – volume: 15 start-page: 11 year: 2014 end-page: 23 ident: bib3 article-title: Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management publication-title: Rev Cardiovasc Med contributor: fullname: Bennett-Guerrero – volume: 351 start-page: 543 year: 2004 end-page: 551 ident: bib7 article-title: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study publication-title: N Engl J Med contributor: fullname: Lee – volume: 347 start-page: 93 year: 2014 end-page: 100 ident: bib10 article-title: Management of hyperkalemia in hospitalized patients publication-title: Am J Med Sci contributor: fullname: Doran – volume: 372 start-page: 222 year: 2015 end-page: 231 ident: bib21 article-title: Sodium zirconium cyclosilicate in hyperkalemia publication-title: N Engl J Med contributor: fullname: Lavin – volume: 112 start-page: 1362 year: 2005 end-page: 1374 ident: bib12 article-title: Renovascular hypertension and ischemic nephropathy publication-title: Circulation contributor: fullname: Textor – volume: 119 start-page: 141 year: 2009 end-page: 147 ident: bib8 article-title: Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients publication-title: Pol Arch Med Wewn contributor: fullname: Janowska-Molenda – volume: 56 start-page: 20d year: 1985 end-page: 23d ident: bib15 article-title: Malignant arrhythmia in relation to serum potassium in acute myocardial infarction publication-title: Am J Cardiol contributor: fullname: Nordrehaug – volume: 5 start-page: 1544 year: 2010 end-page: 1551 ident: bib5 article-title: Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study publication-title: Clin J Am Soc Nephrol contributor: fullname: Gomes – volume: 372 start-page: 211 year: 2015 end-page: 221 ident: bib19 article-title: Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors publication-title: N Engl J Med contributor: fullname: Bushinsky – volume: 109 start-page: 307 year: 2000 end-page: 314 ident: bib9 article-title: Drug-induced hyperkalemia: old culprits and new offenders publication-title: Am J Med contributor: fullname: Perazella – volume: 64 start-page: 811 year: 2014 end-page: 819 ident: bib13 article-title: Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals publication-title: J Am Coll Cardiol contributor: fullname: Marso – volume: 16 start-page: R225 year: 2012 ident: bib2 article-title: Severe hyperkalemia requiring hospitalization: predictors of mortality publication-title: Crit Care contributor: fullname: Jeon – volume: 104 start-page: 1985 year: 2001 end-page: 1991 ident: bib16 article-title: Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association publication-title: Circulation contributor: fullname: Wilcox – volume: 312 start-page: 2223 year: 2014 end-page: 2233 ident: bib20 article-title: Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial publication-title: JAMA contributor: fullname: Lavin – volume: 15 start-page: 11 year: 2014 ident: 10.1016/j.amjmed.2016.03.008_bib3 article-title: Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management publication-title: Rev Cardiovasc Med doi: 10.3909/ricm0727 contributor: fullname: McCullough – volume: 64 start-page: 811 year: 2014 ident: 10.1016/j.amjmed.2016.03.008_bib13 article-title: Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.05.040 contributor: fullname: Salisbury – volume: 118 start-page: 1643 year: 2008 ident: 10.1016/j.amjmed.2016.03.008_bib6 article-title: Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.778811 contributor: fullname: Pitt – volume: 312 start-page: 2223 year: 2014 ident: 10.1016/j.amjmed.2016.03.008_bib20 article-title: Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2014.15688 contributor: fullname: Kosiborod – volume: 91 start-page: 177 year: 2008 ident: 10.1016/j.amjmed.2016.03.008_bib18 article-title: Hyperkalemia during spironolactone use in patients with decompensated heart failure publication-title: Arq Bras Cardiol doi: 10.1590/S0066-782X2008000300004 contributor: fullname: Lima – volume: 119 start-page: 141 year: 2009 ident: 10.1016/j.amjmed.2016.03.008_bib8 article-title: Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients publication-title: Pol Arch Med Wewn contributor: fullname: Wozakowska-Kaplon – volume: 102 start-page: 557 year: 1989 ident: 10.1016/j.amjmed.2016.03.008_bib17 article-title: Hyperkalaemia in patients in hospital publication-title: N Z Med J contributor: fullname: Moore – volume: 372 start-page: 211 year: 2015 ident: 10.1016/j.amjmed.2016.03.008_bib19 article-title: Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors publication-title: N Engl J Med doi: 10.1056/NEJMoa1410853 contributor: fullname: Weir – volume: 112 start-page: 1362 year: 2005 ident: 10.1016/j.amjmed.2016.03.008_bib12 article-title: Renovascular hypertension and ischemic nephropathy publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.104.492348 contributor: fullname: Garovic – volume: 347 start-page: 93 year: 2014 ident: 10.1016/j.amjmed.2016.03.008_bib10 article-title: Management of hyperkalemia in hospitalized patients publication-title: Am J Med Sci doi: 10.1097/MAJ.0b013e318279b105 contributor: fullname: Fordjour – ident: 10.1016/j.amjmed.2016.03.008_bib4 – volume: 16 start-page: R225 year: 2012 ident: 10.1016/j.amjmed.2016.03.008_bib2 article-title: Severe hyperkalemia requiring hospitalization: predictors of mortality publication-title: Crit Care doi: 10.1186/cc11872 contributor: fullname: An – volume: 109 start-page: 307 year: 2000 ident: 10.1016/j.amjmed.2016.03.008_bib9 article-title: Drug-induced hyperkalemia: old culprits and new offenders publication-title: Am J Med doi: 10.1016/S0002-9343(00)00496-4 contributor: fullname: Perazella – volume: 38 start-page: 1834 year: 2012 ident: 10.1016/j.amjmed.2016.03.008_bib14 article-title: Association between hyperkalemia at critical care initiation and mortality publication-title: Intensive Care Med doi: 10.1007/s00134-012-2636-7 contributor: fullname: McMahon – volume: 21 start-page: 261 year: 2005 ident: 10.1016/j.amjmed.2016.03.008_bib11 article-title: Contrast-induced nephropathy publication-title: Crit Care Clin doi: 10.1016/j.ccc.2004.12.003 contributor: fullname: McCullough – volume: 56 start-page: 20d year: 1985 ident: 10.1016/j.amjmed.2016.03.008_bib15 article-title: Malignant arrhythmia in relation to serum potassium in acute myocardial infarction publication-title: Am J Cardiol doi: 10.1016/0002-9149(85)91110-5 contributor: fullname: Nordrehaug – volume: 104 start-page: 1985 year: 2001 ident: 10.1016/j.amjmed.2016.03.008_bib16 article-title: Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association publication-title: Circulation doi: 10.1161/hc4101.096153 contributor: fullname: Schoolwerth – volume: 372 start-page: 222 year: 2015 ident: 10.1016/j.amjmed.2016.03.008_bib21 article-title: Sodium zirconium cyclosilicate in hyperkalemia publication-title: N Engl J Med doi: 10.1056/NEJMoa1411487 contributor: fullname: Packham – volume: 307 start-page: 157 year: 2012 ident: 10.1016/j.amjmed.2016.03.008_bib1 article-title: Serum potassium levels and mortality in acute myocardial infarction publication-title: JAMA doi: 10.1001/jama.2011.1967 contributor: fullname: Goyal – volume: 351 start-page: 543 year: 2004 ident: 10.1016/j.amjmed.2016.03.008_bib7 article-title: Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study publication-title: N Engl J Med doi: 10.1056/NEJMoa040135 contributor: fullname: Juurlink – volume: 5 start-page: 1544 year: 2010 ident: 10.1016/j.amjmed.2016.03.008_bib5 article-title: Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.01970310 contributor: fullname: Weir |
SSID | ssj0000956 |
Score | 2.4031572 |
Snippet | Abstract Background Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after... Hyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute myocardial... Grodzinsky et al determine the contemporary prevalence and prognostic importance of hyperkalemia after acute myocardial infarction. Of 38,689 patients with... BACKGROUNDHyperkalemia is common and potentially dangerous in hospitalized patients; its contemporary prevalence and prognostic importance after acute... |
SourceID | pubmedcentral proquest crossref pubmed elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 858 |
SubjectTerms | Acute myocardial infarction Aged Dialysis Female Heart attacks Hemodialysis Hospital Mortality Humans Hyperkalemia - epidemiology Hyperkalemia - etiology Hyperkalemia - mortality Hyperkalemia - therapy Hyperkalemia prevalence Internal Medicine Male Mortality Myocardial Infarction - complications Myocardial Infarction - mortality Potassium Prevalence Prognosis Registries Renal Dialysis Risk Factors United States - epidemiology |
Title | Prevalence and Prognosis of Hyperkalemia in Patients with Acute Myocardial Infarction |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0002934316303175 https://dx.doi.org/10.1016/j.amjmed.2016.03.008 https://www.ncbi.nlm.nih.gov/pubmed/27060233 https://www.proquest.com/docview/1818704053 https://search.proquest.com/docview/1807080716 https://pubmed.ncbi.nlm.nih.gov/PMC5031155 |
Volume | 129 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHcKAxmJN5TKuSePVRlUVEUTW8XeLMcX0aKlqBek7WfwizknTpx0ZQL20KhKTpzE5_M5x_a5EPI201j0KCs8aQrmgUWcegWIPS_SKUBEqkxkGCg8_ZyMZ9Gn8_i81_vV8VraboqBvPpjXMltuArngK8YJfsfnHWNwgn4D_yFI3AYjv_EY8y_JKqoocbpH93mbIaRMUwwV9_h6sVc4KLGiU2gWkezDSX6B0wvQZOtlM23YQDyjkuLFkRuT6eTZOL6jvxHEMNXWAP70jpJ2kCz6Xu76i0dGa5VVBQFlu3-2SEan7ZEa1ueCnRAvavVWTiXI5gzY2Uh51z8bjjotHMy7q5j-InzouvK5jy0SZv2BLtdY1gMxMUCPhFd8pI6OW2ryJrN--PRxPfWwYB5p9gotglWJ0NLaZfYzoL4OuCM75HeIYcBCC-QmofDyZevk1a_51VNYPe-TUBm5TW4_343GTz7E5rrfrkdQ-fsAblfz1Do0MLtIenp8hG5O605_pjMWtRRQB11qKNLQ7uoo_OSNqijiDpaoY62qKMt6p6Q2Yfjs9HYq4tzeDKOko0XKeEXkVYq98PC-EozYwzu-zMQChJHqTJ5IqSJWFrkMgwDIYSSCYt0FgoVhU_JQbks9XNCwzjRYDkWGRjDUWxA72XCKKkCpQ1Lpe4Tr-lB_sPmYOGNc-KC2x7n2OOchRx6vE_Sppt5E18MGlGv63Gy5jfxvHtnbYFay5IDDv_yzKOGn7x9DFjDIPJAz_XJG3cZ5DduyolSL7dIA0oXfn7SJ88s-91HBpjaKgjh7nQHGI4Ac8PvXinn36oc8THDNFrxi1t3xUtyrx2lR-Rgs9rqV2B_b4rX9YD4DTFZ13Q |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+Prognosis+of+Hyperkalemia+in+Patients+with+Acute+Myocardial+Infarction&rft.jtitle=The+American+journal+of+medicine&rft.au=Grodzinsky%2C+Anna%2C+MD%2C+MSc&rft.au=Goyal%2C+Abhinav%2C+MD%2C+MHS&rft.au=Gosch%2C+Kensey%2C+MS&rft.au=McCullough%2C+Peter+A.%2C+MD%2C+MPH&rft.date=2016-08-01&rft.issn=0002-9343&rft_id=info:doi/10.1016%2Fj.amjmed.2016.03.008&rft.externalDBID=ECK1-s2.0-S0002934316303175&rft.externalDocID=1_s2_0_S0002934316303175 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9343&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9343&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9343&client=summon |